Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm Metastasis × pralsetinib × Clear all

Sponsor

Conditions

Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Neoplasms, Nerve Tissue 2 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lung Neoplasms 2 Lung Diseases 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Adenocarcinoma 2 Thyroid Neoplasms 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors 1 Neoplasms, Glandular and Epithelial 1 Multiple Endocrine Neoplasia Type 2a 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1 Digestive System Neoplasms 1 Digestive System Diseases 1

Interventions

Gemcitabine 42 Paclitaxel 36 pembrolizumab 35 Nivolumab 30 Docetaxel 29 Capecitabine 29 Bevacizumab 29 Oxaliplatin 28 Fluorouracil 28 Cisplatin 26 Leucovorin 24 Cyclophosphamide 23 Carboplatin 20 aldesleukin 19 Radiosurgery 19 Irinotecan 19 Cetuximab 18 Interleukin-2 16 fludarabine phosphate 15 fludarabine 15 Pemetrexed 15 Trastuzumab 14 Ipilimumab 14 Fulvestrant 14 Prednisone 13 Everolimus 13 130-nm albumin-bound paclitaxel 13 Radiotherapy 12 Panitumumab 12 Magnetic Resonance Spectroscopy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡